Low-molecular dextran in chronic circulatory failure. Effect estimated by lung diffusing capacity.
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D003911:Dextrans / Q000627:therapeutic use*; D004058:Diffusion; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008171:Lung Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D010952:Plasma Substitutes / Q000627:therapeutic use; D011650:Pulmonary Alveoli / Q000502:physiology; D011652:Pulmonary Circulation / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*
D003911:Dextrans; D010952:Plasma Substitutes; D014665:Vasodilator Agents